200 related articles for article (PubMed ID: 25726860)
1. Leptin signaling as a therapeutic target of obesity.
Sáinz N; González-Navarro CJ; Martínez JA; Moreno-Aliaga MJ
Expert Opin Ther Targets; 2015 Jul; 19(7):893-909. PubMed ID: 25726860
[TBL] [Abstract][Full Text] [Related]
2. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase.
Jang EH; Moon JS; Ko JH; Ahn CW; Lee HH; Shin JK; Park CS; Kang JH
Int J Obes (Lond); 2008 Jul; 32(7):1161-70. PubMed ID: 18414417
[TBL] [Abstract][Full Text] [Related]
3. [The regulation of body mass and its relation to the development of obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2007 Sep; 148(39):1827-36. PubMed ID: 17890170
[TBL] [Abstract][Full Text] [Related]
4. Latest approaches for the treatment of obesity.
Jackson VM; Breen DM; Fortin JP; Liou A; Kuzmiski JB; Loomis AK; Rives ML; Shah B; Carpino PA
Expert Opin Drug Discov; 2015; 10(8):825-39. PubMed ID: 25967138
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ilex paraguariensis (yerba mate) treatment on leptin resistance and inflammatory parameters in obese rats primed by early weaning.
Lima Nda S; de Oliveira E; da Silva AP; Maia Lde A; de Moura EG; Lisboa PC
Life Sci; 2014 Oct; 115(1-2):29-35. PubMed ID: 25241125
[TBL] [Abstract][Full Text] [Related]
6. Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?
Izquierdo AG; Crujeiras AB; Casanueva FF; Carreira MC
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717265
[TBL] [Abstract][Full Text] [Related]
7. Leptin resistance in obesity: An epigenetic landscape.
Crujeiras AB; Carreira MC; Cabia B; Andrade S; Amil M; Casanueva FF
Life Sci; 2015 Nov; 140():57-63. PubMed ID: 25998029
[TBL] [Abstract][Full Text] [Related]
8. Teasaponin reduces inflammation and central leptin resistance in diet-induced obese male mice.
Yu Y; Wu Y; Szabo A; Wu Z; Wang H; Li D; Huang XF
Endocrinology; 2013 Sep; 154(9):3130-40. PubMed ID: 23751875
[TBL] [Abstract][Full Text] [Related]
9. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
10. A functional leptin system is essential for sodium tungstate antiobesity action.
Canals I; Carmona MC; Amigó M; Barbera A; Bortolozzi A; Artigas F; Gomis R
Endocrinology; 2009 Feb; 150(2):642-50. PubMed ID: 18845634
[TBL] [Abstract][Full Text] [Related]
11. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity.
Popovic V; Duntas LH
Nutr Neurosci; 2005 Feb; 8(1):1-5. PubMed ID: 15909762
[TBL] [Abstract][Full Text] [Related]
12. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats.
Luvizotto Rde A; Nascimento AF; Imaizumi E; Pierine DT; Conde SJ; Correa CR; Yeum KJ; Ferreira AL
Br J Nutr; 2013 Nov; 110(10):1803-9. PubMed ID: 23632237
[TBL] [Abstract][Full Text] [Related]
13. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.
Sáinz N; Barrenetxe J; Moreno-Aliaga MJ; Martínez JA
Metabolism; 2015 Jan; 64(1):35-46. PubMed ID: 25497342
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet.
Saravanan G; Ponmurugan P; Deepa MA; Senthilkumar B
J Sci Food Agric; 2014 Nov; 94(14):2972-7. PubMed ID: 24615565
[TBL] [Abstract][Full Text] [Related]
15. Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation.
de Git KC; Adan RA
Obes Rev; 2015 Mar; 16(3):207-24. PubMed ID: 25589226
[TBL] [Abstract][Full Text] [Related]
16. Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice.
Caricilli AM; Penteado E; de Abreu LL; Quaresma PG; Santos AC; Guadagnini D; Razolli D; Mittestainer FC; Carvalheira JB; Velloso LA; Saad MJ; Prada PO
Endocrinology; 2012 Sep; 153(9):4401-11. PubMed ID: 22822160
[TBL] [Abstract][Full Text] [Related]
17. Phenomenon of leptin resistance in seasonal animals: the failure of leptin action in the brain.
Szczesna M; Zieba DA
Domest Anim Endocrinol; 2015 Jul; 52():60-70. PubMed ID: 25863197
[TBL] [Abstract][Full Text] [Related]
18. New targets for obesity pharmacotherapy.
Aronne LJ; Thornton-Jones ZD
Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
[TBL] [Abstract][Full Text] [Related]
19. New insights in leptin resistance mechanisms in mice.
Balland E; Cowley MA
Front Neuroendocrinol; 2015 Oct; 39():59-65. PubMed ID: 26410445
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
Patel V; Joharapurkar A; Gandhi T; Patel K; Dhanesha N; Kshirsagar S; Dhote V; Detroja J; Bahekar R; Jain M
J Diabetes; 2013 Jun; 5(2):163-71. PubMed ID: 22830490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
